At the news
? NEUTRALIMPACT 2/10 8-K filed Apr 24, 2026 at 06:00 ET
Sana Biotechnology reclassified director Steven D. Harr, M.D. from a Class I to a Class III director to balance board class composition in accordance with its charter. The move was administrative, with no interruption in service, and the board now has three directors in each class.
- Steven D. Harr, M.D. resigned as a Class I director and was immediately reappointed as a Class III director.
- The reclassification was made to achieve equal balance among the three board classes per the company's Certificate of Incorporation.
- Dr. Harr's board service is deemed to have continued uninterrupted.
- The board now consists of three directors in each of Class I, II, and III.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access